Towards Healthcare
Corticosteroids Market Size to Attain USD 8.55 Bn by 2035

Corticosteroids Market Surges with New Treatment Advances

Market insights predict the global corticosteroids industry will increase from USD 5.2 billion in 2025 to USD 8.55 billion by 2035, achieving a CAGR of 5.10%. Corticosteroids are anti-inflammatory drugs that help reduce swelling, redness, and immune responses. They treat conditions like asthma, arthritis, allergies, and autoimmune diseases. Available as pills, inhalers, creams, or injections, they provide relief but may have side effects with long-term use.

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Corticosteroids Market Assessment

  • Overview
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users
  • Global Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Corticosteroids Market Assessment

  • Overview
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • North America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Europe Corticosteroids Market Assessment

  • Overview
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Europe Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Asia Pacific Corticosteroids Market Assessment

  • Overview
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Asia Pacific Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Latin America Corticosteroids Market Assessment

  • Overview
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Latin America Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Middle East and Africa Corticosteroids Market Assessment

  • Overview
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Glucocorticoids
    • Mineralocorticoids
    • Synthetic Corticosteroids
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Topical
    • Oral
    • Inhaled
    • Injectable
    • Ophthalmic
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Rheumatology
    • Dermatology
    • Pulmonology
    • Gastroenterology
    • Neurology
    • Other Applications
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by Product Form (2021 – 2033)
    • Oral
    • Intravenous
    • Nasal
    • Topical
  • Middle East and Africa Corticosteroids Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals and Clinics
    • Pharmacies and Retail
    • Specialty Clinics
    • Other End Users

Company Profiles

  • Pfizer
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Novartis
  • Merck & Co., Inc.
  • GlaxoSmithKline
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Galderma
  • Cipla
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Conclusion & Recommendations

  • Last Updated: 14 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

growth from USD 5.2 billion in 2025 to USD 8.55 billion by 2035, with 5.10% CAGR till 2026 to 2035

Major companies like Pfizer, Novartis, Merck, GSK, AstraZeneca, Sanofi, Cipla, Teva, Bausch Health, and Galderma dominate the corticosteroids industry with strong product portfolios and continuous innovation.

Inhaled corticosteroids are rising in demand because they deliver targeted lung treatment for asthma and COPD, reduce systemic side effects, improve patient compliance, and form essential components of advanced combination therapies.

North America leads due to its robust healthcare infrastructure, high prevalence of asthma and COPD, strong government initiatives for respiratory health, and rapid adoption of new corticosteroid therapies.

The market is segmented by product type glucocorticoids, mineralocorticoids, synthetic, administration routes topical, oral, inhaled, injectable, ophthalmic, applications rheumatology, dermatology, pulmonology, gastroenterology, neurology, product forms, end users, and global regions.
Any Questions